These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 25727248)

  • 1. Age, atrial fibrillation, and structural heart disease are the main determinants of left atrial fibrosis detected by delayed-enhanced magnetic resonance imaging in a general cardiology population.
    Cochet H; Mouries A; Nivet H; Sacher F; Derval N; Denis A; Merle M; Relan J; Hocini M; Haïssaguerre M; Laurent F; Montaudon M; Jaïs P
    J Cardiovasc Electrophysiol; 2015 May; 26(5):484-92. PubMed ID: 25727248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum YKL-40 as a Marker of Left Atrial Fibrosis Assessed by Delayed Enhancement MRI in Lone Atrial Fibrillation.
    Canpolat U; Aytemir K; Hazirolan T; Özer N; Oto A
    Pacing Clin Electrophysiol; 2015 Dec; 38(12):1386-95. PubMed ID: 26256257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left atrial strain and strain rate in patients with paroxysmal and persistent atrial fibrillation: relationship to left atrial structural remodeling detected by delayed-enhancement MRI.
    Kuppahally SS; Akoum N; Burgon NS; Badger TJ; Kholmovski EG; Vijayakumar S; Rao SN; Blauer J; Fish EN; Dibella EV; Macleod RS; McGann C; Litwin SE; Marrouche NF
    Circ Cardiovasc Imaging; 2010 May; 3(3):231-9. PubMed ID: 20133512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective DE-MRI study evaluating the role of TGF-β1 in left atrial fibrosis and implications for outcomes of cryoballoon-based catheter ablation: new insights into primary fibrotic atriocardiomyopathy.
    Canpolat U; Oto A; Hazirolan T; Sunman H; Yorgun H; Şahiner L; Kaya EB; Aytemir K
    J Cardiovasc Electrophysiol; 2015 Mar; 26(3):251-9. PubMed ID: 25366936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Association of Serum Galectin-3 Levels with Atrial Electrical and Structural Remodeling.
    Yalcin MU; Gurses KM; Kocyigit D; Canpinar H; Canpolat U; Evranos B; Yorgun H; Sahiner ML; Kaya EB; Hazirolan T; Tokgozoglu L; Oto MA; Ozer N; Guc D; Aytemir K
    J Cardiovasc Electrophysiol; 2015 Jun; 26(6):635-40. PubMed ID: 25684038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between vitamin D level and left atrial fibrosis in patients with lone paroxysmal atrial fibrillation undergoing cryoballoon-based catheter ablation.
    Canpolat U; Aytemir K; Hazirolan T; Özer N; Oto A
    J Cardiol; 2017 Jan; 69(1):16-23. PubMed ID: 27554047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential regional distribution of atrial fibrosis in posterior wall around left inferior pulmonary vein as identified by late gadolinium enhancement cardiac magnetic resonance in patients with atrial fibrillation.
    Benito EM; Cabanelas N; Nuñez-Garcia M; Alarcón F; Figueras I Ventura RM; Soto-Iglesias D; Guasch E; Prat-Gonzalez S; Perea RJ; Borràs R; Butakoff C; Camara O; Bisbal F; Arbelo E; Tolosana JM; Brugada J; Berruezo A; Mont L
    Europace; 2018 Dec; 20(12):1959-1965. PubMed ID: 29860416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. M2-muscarinic acetylcholine receptor autoantibody levels predict left atrial fibrosis severity in paroxysmal lone atrial fibrillation patients undergoing cryoablation.
    Gurses KM; Yalcin MU; Kocyigit D; Kesikli SA; Canpolat U; Yorgun H; Sahiner ML; Kaya EB; Hazirolan T; Ozer N; Oto MA; Guc D; Aytemir K
    Europace; 2015 Feb; 17(2):239-46. PubMed ID: 25238749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study.
    Marrouche NF; Wilber D; Hindricks G; Jais P; Akoum N; Marchlinski F; Kholmovski E; Burgon N; Hu N; Mont L; Deneke T; Duytschaever M; Neumann T; Mansour M; Mahnkopf C; Herweg B; Daoud E; Wissner E; Bansmann P; Brachmann J
    JAMA; 2014 Feb; 311(5):498-506. PubMed ID: 24496537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of quantification methods for left arial late gadolinium enhancement based on different references in patients with atrial fibrillation.
    Hwang SH; Oh YW; Lee DI; Shim J; Park SW; Kim YH
    Int J Cardiovasc Imaging; 2015 Jun; 31 Suppl 1():91-101. PubMed ID: 25367893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between left atrial tissue structural remodelling detected using late gadolinium enhancement MRI and left ventricular hypertrophy in patients with atrial fibrillation.
    Akkaya M; Higuchi K; Koopmann M; Burgon N; Erdogan E; Damal K; Kholmovski E; McGann C; Marrouche NF
    Europace; 2013 Dec; 15(12):1725-32. PubMed ID: 23711578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between AF substrate ablation difficulty and left atrial fibrosis quantified by delayed-enhancement cardiac magnetic resonance.
    Seitz J; Horvilleur J; Lacotte J; O H-Ici D; Mouhoub Y; Maltret A; Salerno F; Mylotte D; Monchi M; Garot J
    Pacing Clin Electrophysiol; 2011 Oct; 34(10):1267-77. PubMed ID: 21651593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electroanatomic remodeling of the left atrium in paroxysmal and persistent atrial fibrillation patients without structural heart disease.
    Teh AW; Kistler PM; Lee G; Medi C; Heck PM; Spence SJ; Sparks PB; Morton JB; Kalman JM
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):232-8. PubMed ID: 21955090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of Late Gadolinium Enhancement - Magnetic Resonance Imaging in the Measurement of Left Atrial Substrate Remodeling in Patients With Rheumatic Mitral Valve Disease and Persistent Atrial Fibrillation.
    Zhu D; Wu Z; van der Geest RJ; Luo Y; Sun J; Jiang J; Chen Y
    Int Heart J; 2015; 56(5):505-10. PubMed ID: 26370371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrosis in non-atrial fibrillation individuals and prediction of atrial fibrillation by use of late gadolinium enhancement magnetic resonance imaging.
    Siebermair J; Suksaranjit P; McGann CJ; Peterson KA; Kheirkhahan M; Baher AA; Damal K; Wakili R; Marrouche NF; Wilson BD
    J Cardiovasc Electrophysiol; 2019 Apr; 30(4):550-556. PubMed ID: 30661270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Spatial Distribution of Late Gadolinium Enhancement of Left Atrial Magnetic Resonance Imaging in Patients With Atrial Fibrillation.
    Higuchi K; Cates J; Gardner G; Morris A; Burgon NS; Akoum N; Marrouche NF
    JACC Clin Electrophysiol; 2018 Jan; 4(1):49-58. PubMed ID: 29600786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged atrial effective refractory periods in atrial fibrillation patients associated with structural heart disease or sinus node dysfunction compared with lone atrial fibrillation.
    Uhm JS; Mun HS; Wi J; Shim J; Joung B; Lee MH; Pak HN
    Pacing Clin Electrophysiol; 2013 Feb; 36(2):163-71. PubMed ID: 23121003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural abnormalities in atrial walls are associated with presence and persistency of atrial fibrillation but not with age.
    Platonov PG; Mitrofanova LB; Orshanskaya V; Ho SY
    J Am Coll Cardiol; 2011 Nov; 58(21):2225-32. PubMed ID: 22078429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left Atrial 4-Dimensional Flow Magnetic Resonance Imaging: Stasis and Velocity Mapping in Patients With Atrial Fibrillation.
    Markl M; Lee DC; Ng J; Carr M; Carr J; Goldberger JJ
    Invest Radiol; 2016 Mar; 51(3):147-54. PubMed ID: 26488375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffuse ventricular fibrosis measured by T₁ mapping on cardiac MRI predicts success of catheter ablation for atrial fibrillation.
    McLellan AJ; Ling LH; Azzopardi S; Ellims AH; Iles LM; Sellenger MA; Morton JB; Kalman JM; Taylor AJ; Kistler PM
    Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):834-40. PubMed ID: 25141860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.